. Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease. NPJ Parkinsons Dis. 2025 Jan 4;11(1):9. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.